Utility of medical and drug history in fracture risk prediction among men and women
Utility of medical and drug history in fracture risk prediction among men and women
Preventive strategies against osteoporotic fracture depend, in part, on the availability of simple risk prediction tools whereby pharmacological therapy may be targeted to those at greatest risk. The objective of this study was to evaluate the performance of a series of risk factors routinely listed in primary care records for the prediction of future fracture. Information was obtained from the UK General Practice Research Database, which contains the general practitioner medical records of around 6% of the UK population. We performed a case-control study of all 231,778 adult patients with a recorded fracture between 1988 and 1999 and an equal number of controls, individually matched by age, gender, and medical practice to the cases. In addition to a previous history of fracture, 11 items were identified that independently predicted fracture risk (history of anemia, dementia, cerebrovascular disease, and chronic obstructive pulmonary disease; recent use of oral corticosteroids, anticonvulsants, nonsteroidal anti-inflammatory drugs [NSAIDs], antiarrythmics, hypnotics/anxiolytics, antidepressants, and anti-Parkinson drugs). Three or more of these medical risk factors increased the risk of a vertebral fracture 8.1 times (95% confidence interval [CI] 7.0–9.4) and of hip fracture by 4.6 times (95% CI 4.3–5.0), when compared with subjects without these attributes. The optimum screening characteristics of the risk factors for prediction of vertebral fracture revealed a sensitivity 66%, and specificity 89%. These values were 61% and 68%, respectively, for hip fracture. The positive predictive value (PPV) for fracture over a 5 year period improved with the addition of age and previous fracture history to the number of medical risk factors. PPV rose from 8.4% for women aged 65 years without risk factors or fracture history, compared with 26.8% if women had sustained a previous fracture and had three or more risk factors recorded. The data suggest that routinely recorded medical risk factors permit identification of groups of patients with a substantial increase in future risk of fracture. Further investigations, such as bone densitometry, might be conveniently targeted at this group of patients.
epidemiology, osteoporosis, risk factors, screening
508-514
van Staa, T.P.
31b8bfb4-4e1b-4a48-a5a6-90ca601b94af
Leufkens, H.G.M.
04854167-bea6-4508-a8e2-aeb920a2d6b1
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
2002
van Staa, T.P.
31b8bfb4-4e1b-4a48-a5a6-90ca601b94af
Leufkens, H.G.M.
04854167-bea6-4508-a8e2-aeb920a2d6b1
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
van Staa, T.P., Leufkens, H.G.M. and Cooper, C.
(2002)
Utility of medical and drug history in fracture risk prediction among men and women.
Bone, 31 (4), .
(doi:10.1016/S8756-3282(02)00848-7).
Abstract
Preventive strategies against osteoporotic fracture depend, in part, on the availability of simple risk prediction tools whereby pharmacological therapy may be targeted to those at greatest risk. The objective of this study was to evaluate the performance of a series of risk factors routinely listed in primary care records for the prediction of future fracture. Information was obtained from the UK General Practice Research Database, which contains the general practitioner medical records of around 6% of the UK population. We performed a case-control study of all 231,778 adult patients with a recorded fracture between 1988 and 1999 and an equal number of controls, individually matched by age, gender, and medical practice to the cases. In addition to a previous history of fracture, 11 items were identified that independently predicted fracture risk (history of anemia, dementia, cerebrovascular disease, and chronic obstructive pulmonary disease; recent use of oral corticosteroids, anticonvulsants, nonsteroidal anti-inflammatory drugs [NSAIDs], antiarrythmics, hypnotics/anxiolytics, antidepressants, and anti-Parkinson drugs). Three or more of these medical risk factors increased the risk of a vertebral fracture 8.1 times (95% confidence interval [CI] 7.0–9.4) and of hip fracture by 4.6 times (95% CI 4.3–5.0), when compared with subjects without these attributes. The optimum screening characteristics of the risk factors for prediction of vertebral fracture revealed a sensitivity 66%, and specificity 89%. These values were 61% and 68%, respectively, for hip fracture. The positive predictive value (PPV) for fracture over a 5 year period improved with the addition of age and previous fracture history to the number of medical risk factors. PPV rose from 8.4% for women aged 65 years without risk factors or fracture history, compared with 26.8% if women had sustained a previous fracture and had three or more risk factors recorded. The data suggest that routinely recorded medical risk factors permit identification of groups of patients with a substantial increase in future risk of fracture. Further investigations, such as bone densitometry, might be conveniently targeted at this group of patients.
This record has no associated files available for download.
More information
Published date: 2002
Keywords:
epidemiology, osteoporosis, risk factors, screening
Identifiers
Local EPrints ID: 26065
URI: http://eprints.soton.ac.uk/id/eprint/26065
ISSN: 8756-3282
PURE UUID: 4b742ebd-d57d-459e-b57b-c90083661867
Catalogue record
Date deposited: 20 Apr 2006
Last modified: 18 Mar 2024 02:44
Export record
Altmetrics
Contributors
Author:
T.P. van Staa
Author:
H.G.M. Leufkens
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics